The US Food and Drug Administration (FDA) has revised a 2023 draft guidance on master protocols for drug and biological ...
In order to address the specific details and regulatory requirements present in a retrospective medical chart review, the UB IRB recently created a new Protocol template: the HRP-503R. In order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results